Seralutinib T8900
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Seralutinib is an inhibitor of inhaled PDGFR_ and PDGFR_. It is used in the study for pulmonary arterial hypertension.
CAS nr:
1619931-27-9
Purity:
98%
Molecular Weight:
469,55
SMILES:
CC1=CC(=CN=C1)C(=O)NC2=CC=CC(=C2)[C@H](C)NC3=NC(=CN=C3)C4=CC(=C(C=C4)OC)OC
Formula:
C27H27N5O3
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors
Target:
PDGFR,PDGFR
